Intrarenal display of cytotoxic attack molecules during rejection.
Sharma
V K
VK
Rogosin Institute, Department of Transplantation Medicine & Extracorporeal Therapy, New York Hospital-Cornell Medical Center, NY 10021, USA.
Bologa
R M
RM
Li
B
B
Xu
G P
GP
Lagman
M
M
Mouradian
J
J
Wang
J
J
Serur
D
D
Rao
V K
VK
Suthanthiran
M
M
D000208:Acute Disease; D017209:Apoptosis; D001707:Biopsy, Needle; D053222:Fas Ligand Protein; D006084:Graft Rejection / Q000276:immunology* / Q000473:pathology; D053804:Granzymes; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000096:biosynthesis; D012697:Serine Endopeptidases / Q000096:biosynthesis*; D014158:Transcription, Genetic; D019014:fas Receptor
C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D012333:RNA, Messenger; D019014:fas Receptor; C509213:GZMB protein, human; D053804:Granzymes; D012697:Serine Endopeptidases